Stay updated on Dapagliflozin Sodium Excretion Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.

Latest updates to the Dapagliflozin Sodium Excretion Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no content, data, or functional changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a new site revision label (v3.4.1) and removal of the previous v3.4.0; no study details, enrollment, or trial information appear to be affected—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedMinor UI and metadata updates include glossary show/hide controls, capitalization tweaks on labels, and an updated revision indicator (v3.4.0), with no changes to core study content, outcomes, or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedThe page's revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Sodium Excretion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Sodium Excretion Clinical Trial page.